New FDA Initiatives Aim to Spur Innovation

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2003
Volume 27
Issue 8

Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology